about
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitorGenetics of sputum gene expression in chronic obstructive pulmonary diseaseRisk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary diseaseMicrofibrillar-associated protein 4: A potential biomarker of chronic obstructive pulmonary diseaseGenetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis.Variants in FAM13A are associated with chronic obstructive pulmonary disease.Multiple biomarkers predict disease severity, progression and mortality in COPD.A diVIsive Shuffling Approach (VIStA) for gene expression analysis to identify subtypes in Chronic Obstructive Pulmonary DiseaseSputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study.Characterisation of COPD heterogeneity in the ECLIPSE cohortAltered gene expression in blood and sputum in COPD frequent exacerbators in the ECLIPSE cohort.Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypeNon-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitusCommon genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease.Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease.Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD.SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humansCOPD association and repeatability of blood biomarkers in the ECLIPSE cohort.The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjects.A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts.Functional capacity, health status, and inflammatory biomarker profile in a cohort of patients with chronic obstructive pulmonary disease.The use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPD.COPD subtypes identified by network-based clustering of blood gene expression.Genetic control of gene expression at novel and established chronic obstructive pulmonary disease lociFluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers.Blood fibrinogen as a biomarker of chronic obstructive pulmonary diseaseThe 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool. Insights from the COPD Biomarker Qualification Consortium.Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study.More than just innate immunity: comparative analysis of Chlamydophila pneumoniae and Chlamydia trachomatis effects on host-cell gene regulation.Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: a translational review.The COPD Biomarker Qualification Consortium (CBQC).Lessons from ECLIPSE: a review of COPD biomarkers.Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema.Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.Socioeconomic Status as a Determinant of Health Status Treatment Response in COPD Trials.Baseline Severity as Predictor of Change in St George's Respiratory Questionnaire Scores in Trials of Long-acting Bronchodilators with COPD Patients.Responder Analyses for Treatment Effects in COPD Using the St George's Respiratory Questionnaire.The COPD Biomarkers Qualification Consortium Database: Baseline Characteristics of the St George's Respiratory Questionnaire Dataset.
P50
Q28270421-4CC0ACD4-4881-46D2-A19B-C43E28E16F9CQ28740314-2B5D1F7F-CB85-422A-8456-D2FCF2977A30Q29416987-41ECC8B0-6072-4716-B8DB-21856DC0D678Q29416995-D3234640-1E43-4172-9CB1-AB468149A741Q30160748-B1903DB2-49A9-4A62-9F9E-80C97FF2A690Q30274832-77C53333-1BFC-4607-A618-1A797A4FCEEAQ33687879-C641CC4B-E2DA-40E1-BFE3-4AAF6B9DF26DQ33796180-05E387E5-962E-42B6-8C12-4E40BDABE8D9Q33913351-8291A6BB-529A-494D-8B2E-DB884556E38FQ33995697-A6729EA8-5C45-4DB6-9104-46FED8272C92Q34149510-AB95761B-05B8-46F5-97E9-0CDCA2BF6721Q34263854-D9416FFE-2ABD-4393-A5E9-C6C6629C1694Q34280020-61DE9577-0E03-4E63-AC0B-6BED8E229872Q34436462-7E82166A-C0C5-44CF-81F2-CF3EA7111939Q34471260-FE11465C-4D23-4EBB-86B9-BDFF467E1403Q35042489-E088C57B-659F-4919-97B4-0BCEA4A74C00Q35077912-67A773C3-D3FB-47AD-8B0F-C725AFF8D23DQ35183636-588EAF9F-212C-491D-9700-50C81CF76BAEQ35637295-4D96238D-91DC-4605-B538-AD727ED36897Q35669293-AD8815BB-26DB-46DE-BF5A-C6B0762E6B04Q35816887-4F1F65D8-4E4A-48A0-8635-B223E5C552D2Q35822156-CA5F188B-B145-4B52-B148-09898FED9CAEQ36000101-C9335607-55F8-4697-B125-B586F7177076Q36535812-229BBCC0-23DD-422C-99E8-299D94246048Q36600359-0651CC01-CA11-4F7B-BD0A-602DC86CAD4CQ36724956-F8DB3880-BACF-4D15-877B-4763897BDB7FQ36725405-2758D233-2BD3-4A46-9268-8EA33D9A4E0BQ37012728-3F117943-1EDF-4AEA-B680-C7D4A829FE2BQ37559927-564FF831-5A0A-477E-9665-0612DEEEBE8EQ37592722-63D93DE9-ABFC-4E95-BDFC-3F0F2F1C70BAQ37868448-6DC66600-A17F-4699-956A-C98F1519DFC3Q38007797-4EB753D1-E6A8-4293-BE6B-9A55B9DDC196Q38109909-6E1E12BB-B640-4AEB-B99A-491DABA2FC42Q38169066-0603912D-F43C-45FD-9658-C0A7F144827AQ38452733-B0795E13-B7D5-42EA-90B3-FE027FC80FBDQ38541559-59882FAE-7753-4C2A-900F-D28421EC2509Q38604595-AC7572B7-7DD7-4FA4-BBED-CDD52301325DQ38604599-5532F89C-0AAC-4F31-9066-2DC0942F3BD2Q38604602-F0F8CDD9-0778-4376-90D5-99FADDF82278Q38604605-46C6202D-AFA7-4FD3-B4E2-60B1DAB4A5DA
P50
name
Ruth Tal-Singer
@en
Ruth Tal-Singer
@nl
type
label
Ruth Tal-Singer
@en
Ruth Tal-Singer
@nl
prefLabel
Ruth Tal-Singer
@en
Ruth Tal-Singer
@nl